Published in Calif Med on September 01, 1968
Treatment of thyrotoxicosis. Calif Med (1970) 0.75
The hydrolysis of rabbit y-globulin and antibodies with crystalline papain. Biochem J (1959) 31.27
Separation of univalent fragments from the bivalent rabbit antibody molecule by reduction of disulfide bonds. Arch Biochem Biophys (1960) 13.40
Reduction of gamma-globulins. Arch Biochem Biophys (1962) 13.22
PASSAGE OF NATIVE PROTEINS THROUGH THE NORMAL GASTRO-INTESTINAL WALL. J Clin Invest (1934) 5.93
The effect of adrenocorticotropin and cortisone on thyroid function; thyroid-adrenocortical interrelationships. J Clin Endocrinol Metab (1950) 3.34
ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA. J Clin Endocrinol Metab (1964) 2.78
Radioimmunoassay of thyrotropin in human serum. J Clin Endocrinol Metab (1965) 2.01
Delayed thyroid response to serum from thyrotoxic patients. Endocrinology (1958) 1.99
Absorption of vitamin B12 in pernicious anaemia; defective absorption induced by prolonged oral treatment. Lancet (1958) 1.88
RADIOIMMUNOASSAY OF HUMAN PLASMA THYROTROPIN. J Clin Invest (1965) 1.68
NEONATAL GRAVES' DISEASE. J Clin Endocrinol Metab (1964) 1.54
THYROID AUTO-IMMUNITY AS A DISORDER OF IMMUNOLOGICAL TOLERANCE. Q J Exp Physiol Cogn Med Sci (1964) 1.44
THYROTROPIN AND LONG-ACTING THYROID STIMULATOR ASSAYS IN THYROID DISEASE. J Clin Endocrinol Metab (1965) 1.43
Autoimmunity and chromosomal aberrations. Am J Hum Genet (1966) 1.41
PATHOGENESIS OF THE HYPERTHYROIDISM OF GRAVES'S DISEASE. Br Med J (1965) 1.39
Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics (1965) 1.39
Neonatal hyperthyroidism. N Engl J Med (1963) 1.36
Inhibition of long-acting thyroid stimulator by thyroid particulate fractions. J Clin Invest (1966) 1.35
Occurrence in thyrotoxicosis of a gamma globulin which protects LATS from neutralization by an extract of thyroid gland. J Clin Endocrinol Metab (1967) 1.30
Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab (1967) 1.26
Recovery of the long-acting thyroid stimulator from serum of patients with thyrotoxicosis by concentration of immunoglobulin G. Clin Sci (1966) 1.25
Remission of hyperthyroidism (Graves' disease) and altered pattern of serum-thyroxine binding induced by prednisone. Lancet (1965) 1.24
CHARACTERIZATION OF THE LONG-ACTING THYROID STIMULATOR OF GRAVES' DISEASE. Proc Natl Acad Sci U S A (1964) 1.23
Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes. J Clin Endocrinol Metab (1968) 1.19
Thyrotoxicosis in a newborn infant. Proc R Soc Med (1950) 1.19
Absorption of the long-acting thyroid stimulator by human thyroid microsomes. J Endocrinol (1966) 1.17
Mongolism and thyroid autoimmunity. Lancet (1965) 1.15
Graves' disease without hyperthyroidism. Am J Med (1965) 1.14
The association of grave's disease with myasthenia gravis, with a report of five cases. Ann Intern Med (1951) 1.13
EFFECT OF EMOTIONAL STRESS AND TSH ON THYROID VEIN HORMONE LEVEL IN SHEEP WITH EXTERIORIZED THYROIDS. Endocrinology (1964) 1.11
Absorption of thyroid-stimulating globulin from thyrotoxic sera by organ homogenates. Nature (1966) 1.09
Hyperthyroidism in the first year of life; report of a case occurring in the neonatal period. S Afr Med J (1951) 1.08
Relation between long-acting thyroid stimulator and thyroid function in thyrotoxicosis. Lancet (1966) 1.08
Graves's disease and total thyroidectomy. Progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation. N Engl J Med (1967) 1.07
REVIEW: PATHOGENESIS OF GRAVES' DISEASE: ROLE OF THE LONG-ACTING THYROID STIMULATOR. J Clin Endocrinol Metab (1965) 1.04
Clinical correlation of pretibial myxedema with malignant exophthalmos. Ann Intern Med (1954) 1.02
GLUCOCORTICOID-INDUCED DISAPPEARANCE OF LONG-ACTING THYROID STIMULATOR IN THE OPHTHALMOPATHY OF GRAVES' DISEASE. J Clin Endocrinol Metab (1964) 0.98
Hashimoto's thyroiditis. Clinical and laboratory response to prolonged cortisone therapy. N Engl J Med (1962) 0.97
A comparison of the rates at which thyrotrophin and the human abnormal thyroid stimulator disappear from the circulating blood of the rat. Endocrinology (1960) 0.96
IMMUNOLOGICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR. Clin Sci (1965) 0.94
Uptake of antibodies by the intestine of the newborn infant. Am J Dis Child (1962) 0.93
Thyroid adenomas and thyrotoxicosis in patients with hypopituitarism following hypophysectomy. J Clin Endocrinol Metab (1959) 0.92
Comparative effects of long-acting thyroid stimulator and pituitary thyrotropin on the intermediate metabolism of thyroid tissue in vitro. Endocrinology (1966) 0.92
CLINICAL STUDIES ON THE LONG-ACTING THYROID STIMULATOR. J Clin Endocrinol Metab (1964) 0.92
Observations on the discharge of radio-iodine from the thyroid glands of mice injected with human sera. J Endocrinol (1959) 0.92
PARALLEL ASSAYS OF THYROTROPHIN, LONG-ACTING THYROID STIMULATOR AND EXOPHTHALMOS-PRODUCING SUBSTANCE IN ENDOCRINE EXOPHTHALMOS AND PRETIBIAL MYXEDEMA. J Clin Endocrinol Metab (1964) 0.90
NEONATAL GRAVES' DISEASE. Am J Dis Child (1964) 0.90
RELENTLESS LOCALIZED MYXEDEMA, WITH EXOPHTHALMOS, CLUBBING OF THE FINGERS AND HYPERTROPHIC OSTEOARTHROPATHY: OBSERVATIONS ON AN UNUSUAL CASE. Am J Med (1965) 0.90
SELECTIVE AND DIRECTIONAL TRANSFER OF 7S GAMMA-2-GLOBULIN ACROSS THE HUMAN PLACENTA. Nature (1964) 0.90
LATS production by lymphocyte culture in patients with Graves' disease. J Clin Endocrinol Metab (1967) 0.89
Thyroid disorders in the newborn. Br Med J (1957) 0.87
REDUCTION OF GAMMA GLOBULIN WITH LONG-ACTING THYROID-STIMULATING ACTIVITY. Lancet (1964) 0.87
The response of hypophysectomized mice to injections of human serum containing long-acting thyroid stimulator. Endocrinology (1961) 0.87
Hyperthyroidism in patients with mongolism. J Clin Endocrinol Metab (1962) 0.87
NEONATAL HYPERTHYROIDISM. J Pediatr (1964) 0.86
Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick. Endocrinology (1967) 0.84
The gamma globulin of Graves' disease: thyroid stimulation by fraction and fragment. Trans Assoc Am Physicians (1965) 0.84
Failure of immunologic reaction of long acting thyroid stimulator (LATS) to thyroid components, and the demonstration of a plasma inhibitor LATS. J Lab Clin Med (1967) 0.84
DISSOCIATION AND SEPARATION OF GAMMA GLOBULIN INTO SUBUNITS. Arch Biochem Biophys (1964) 0.83
Thyrotoxicosis in a mongol. J Clin Endocrinol Metab (1956) 0.83
Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum. J Clin Endocrinol Metab (1966) 0.83
EVIDENCE OF A NORMALLY FUNCTIONING PITUITARY TSH SECRETION MECHANISM IN A PATIENT WITH A HIGH BLOOD LEVEL OF LONG-ACTING THYROID STIMULATOR. J Clin Endocrinol Metab (1965) 0.82
Occurrence of hyperthyroidism in patients receiving thyroid hormone. J Clin Endocrinol Metab (1967) 0.81
The severe eye changes of Graves' disease. JAMA (1961) 0.80
Effect of prednisolone and triiodothyronine on thyroid function in hyperthyroidism. J Clin Endocrinol Metab (1963) 0.79
Hyperthyroidism in a patient with a pituitary chromophobe adenoma and a fragment of normal pituitary. J Clin Endocrinol Metab (1958) 0.79
NEONATAL GRAVES' DISEASE. Ann Intern Med (1965) 0.79
Localized myxedema in relation to thyrotoxicosis and exophthalmos. Am J Med Sci (1951) 0.76
LOCALIZED (PRETIBIAL) MYXEDEMA: REPORT OF TWO CASES. Postgrad Med (1964) 0.76
The chemistry of thyrotrophin. Proc R Soc Med (1962) 0.76
Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int (1985) 4.76
Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology (1974) 1.92
Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr (1979) 1.67
Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab (1973) 1.66
Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65
Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics (1965) 1.39
Reproducibility of thallium-201 myocardial imaging. Circulation (1977) 1.36
HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab (1974) 1.33
Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab (1967) 1.26
Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab (1970) 1.11
Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. J Nucl Med (1985) 1.08
Screening for bone metastases. Are only scans necessary? JAMA (1975) 1.06
Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab (1971) 1.06
Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res (1975) 1.05
Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology (1976) 1.04
Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med (1972) 1.02
Allogeneic cytolysis of reconstituted membrane vesicles. Proc Natl Acad Sci U S A (1979) 0.98
Radioisotopic angiocardiography: findings in congenital heart disease. J Nucl Med (1972) 0.98
Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab (1971) 0.97
Interpolative background subtraction. J Nucl Med (1976) 0.94
Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study. Proc Natl Acad Sci U S A (1974) 0.93
Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab (1986) 0.91
The influence of lipid substitution on thyrotropin-receptor interactions in artificial vesicles. Endocrinology (1977) 0.91
Radioisotopic angiocardiography. Wide scope of applicability in diagnosis and evaluation of therapy in diseases of the heart and great vessels. Circulation (1971) 0.91
In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med (1975) 0.91
Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab (1973) 0.90
Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies. J Clin Endocrinol Metab (1970) 0.89
HL-A antigens in Japanese Patients with Graves' disease. Tissue Antigens (1975) 0.89
Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol (1977) 0.88
Unruptured aneurysm of the sinus of valsalva producing right ventricular outflow obstruction. Am J Med (1972) 0.88
Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci (1983) 0.88
Computed tomography in Graves' ophthalmopathy. Radiology (1976) 0.88
Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A (1979) 0.87
Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys (1980) 0.87
Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J Clin Endocrinol Metab (1968) 0.85
Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum. J Clin Endocrinol Metab (1977) 0.85
Sounding board: On white coats and other matters. N Engl J Med (1975) 0.85
The long-acting thyroid stimulator and thyroid disease. Adv Intern Med (1970) 0.84
Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab (1979) 0.83
The diagnosis of intracardiac metastasis of colon carcinoma by radioisotopic and roentgenographic studies. Am J Cardiol (1970) 0.83
Helper and suppressor activities of lymphocyte subsets on antithyroglobulin production in vitro. J Clin Endocrinol Metab (1985) 0.82
Purification of human anti-thyroglobulin. J Clin Endocrinol Metab (1975) 0.81
Tc99m labelled toluidine blue O for liver scintillography. Int J Appl Radiat Isot (1968) 0.81
Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys (1985) 0.80
Combined superior vena cava obstruction and pericardial effusion demonstrated by radioisotopic angiocardiography. J Nucl Med (1970) 0.80
Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases. J Clin Endocrinol Metab (1982) 0.79
Peripheral blood lymphocytes from normal individuals can be induced to secrete immunoglobulin G antibodies against self-antigen thyroglobulin in vitro. J Clin Endocrinol Metab (1985) 0.79
In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids. J Clin Invest (1968) 0.79
Radioisotopic angiocardiography. Preoperative and postoperative evaluation of patients with diseases of the heart and aorta. Radiol Clin North Am (1971) 0.79
Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies. J Nucl Med (1975) 0.78
Distribution and scintiphotography of a new complex, pentavalent technetium-99m citrate: studies in the rodent. J Nucl Med (1967) 0.78
A solid phase, sandwich-type radioimmunoassay for antithyroglobulin: elimination of false positive results and semiquantitative measurement of antithyroglobulin in the presence of elevated thyroglobulin. J Clin Endocrinol Metab (1979) 0.78
New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease. Scott Med J (1974) 0.77
Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide. J Clin Endocrinol Metab (1967) 0.77
Alteration of mammalian cells by interaction with artificial lipid vesicles. Cancer Res (1976) 0.77
Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphoma. Cancer (1976) 0.76
Treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J (1979) 0.75
Simple evaluation of thyroid function. West J Med (1988) 0.75
Editorial: Hyperthyroidism. Calif Med (1970) 0.75
Diagnosis of pericardial effusion by radioisotopic angiocardiography. J Nucl Med (1969) 0.75
Diagnosis of congenital and acquired cardiovascular diseases by radioisotopic angiocardiography. Trans Assoc Am Physicians (1969) 0.75
Studies of radiopharmaceutical-enclosing lipid-protein vesicles formed from native plasma components. J Nucl Med (1977) 0.75
Video instrumentation for radionuclide angiocardiography. Am J Cardiol (1973) 0.75
Vesicle interactions with antibody and peptide hormone: role of vesicle composition. J Nucl Med (1976) 0.75
Biological activity of autoantibodies associated with Graves' dermopathy. J Clin Endocrinol Metab (1989) 0.75
Preparation and binding of antimicrosomal antibody-free LATS, and the effect of iodination on LATS biological activity. J Clin Endocrinol Metab (1971) 0.75
An improved assay for thyrotropin-binding blocking activity in serum of patients with Graves' disease. J Endocrinol Invest (1984) 0.75
[Proceedings: Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex with the membrane fraction of the extraocular muscle]. Nihon Naibunpi Gakkai Zasshi (1974) 0.75
Degradation of C14-labeled thymidine and its halogenated analogues in man. Adv Tracer Methodol (1966) 0.75
Scintiphotographic studies of acquired cardiovascular disease. Semin Nucl Med (1973) 0.75
Acute intracardiac volume changes demonstrated with radioisotopic angiocardiography. J Thorac Cardiovasc Surg (1972) 0.75
A study of o-cresolphthalexon and its analogs as cholescintigraphic 111In carriers. Invest Radiol (1978) 0.75
Radioisotopic angiocardiography: findings in mitral stenosis and mitral insufficiency. J Nucl Med (1970) 0.75
Letter: Orbital radiotherapy for the ophthalmopathy of Graves's disease. N Engl J Med (1974) 0.75
Albumin-loading effect: a pitfall in saline paper analysis of 99mTc-albumin. J Nucl Med (1974) 0.75
Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates. Endocrinology (1977) 0.75
Technetium-99m(V)-citrate complex for estimation of glomerular filtration rate. Nature (1967) 0.75
Congressional Image of NIH. Science (1963) 0.75
Indium bone marrow scintigraphy as an aid in selecting marrow biopsy sites for the evaluation of marrow elements in patients with lymphoma. Cancer (1976) 0.75
Robert Reid Newell, 1892-1965. J Nucl Med (1966) 0.75
Distribution and scintiphotography studies of 99mTc-iron colloid in the rabbit. J Nucl Med (1969) 0.75
Distribution and scintiphotography of a new lung-scanning agent, 99mTc-macroaggregated thionin: studies in the rodent. J Nucl Med (1969) 0.75
The accuracy of 111InCl3 as a bone marrow scanning agent. Radiology (1976) 0.75
HLA antigens in Japanese patients with Graves' disease and Hashimoto's disease [proceedings]. Diabete Metab (1976) 0.75
Guidelines and criteria for a committee authorizing the use of radioactive isotopes in humans. J Nucl Med (1967) 0.75
Variable time-lapse videoscintiscope: a modification of the scintillation camera designed for rapid flow studies. J Nucl Med (1969) 0.75
Reliability and reproducibility of interpretation of 99mtechnetium pyrophosphate myocardial scintigrams. Clin Cardiol (1979) 0.75
Multiple left ventricular outflow obstructions. Aortic valvular and supravalvular stenosis and coarctation of the aorta. J Thorac Cardiovasc Surg (1972) 0.75
Radioisotopic coronary arteriography. Kaku Igaku (1972) 0.75
Selective, symmetric, skeletal muscle uptake of Tc-99m pyrophosphate in rhabdomyolysis. Clin Nucl Med (1985) 0.75
A method to optimise the use of a grayshade scale in nuclear medicine images. Comput Biomed Res (1976) 0.75
Lipid vesicle interaction with EMT-6 tumor cells and effect on subsequent cell growth. Biochem Biophys Res Commun (1976) 0.75